Literature DB >> 22431590

Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.

Fiorenza Cocchi1, Anthony L DeVico, Wuyuan Lu, Mikulas Popovic, Olga Latinovic, Mohammad M Sajadi, Robert R Redfield, Mark K Lafferty, Massimo Galli, Alfredo Garzino-Demo, Robert C Gallo.   

Abstract

T-cell-derived soluble factors that inhibit both X4 and R5 HIV are recognized as important in controlling HIV. Whereas three β chemokines, regulated-on-activation normal T-cell expressed and secreted (RANTES), macrophage inflammatory protein (MIP)-1α, and MIP-1β, account for the suppression of R5 HIV by blockade of HIV entry, the major components responsible for the inhibition of X4 HIV strains have not been identified previously. We identify these factors primarily as a mixture of three β chemokines [macrophage-derived chemokine (MDC), thymus and activation-regulated chemokine (TARC), and I-309] and two RNases (angiogenin and RNase 4) of lesser potency and show that in a clade B population, some correlate with clinical status and are produced by both CD4(+) and CD8(+) T cells (chemokines, angiogenin) or only by CD8(+) T cells (RNase 4). The antiviral mechanisms of these HIV X4-suppressive factors differ from those of the previously described HIV R5-suppressive β chemokines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431590      PMCID: PMC3325691          DOI: 10.1073/pnas.1202240109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.

Authors:  A Garzino-Demo; R B Moss; J B Margolick; F Cleghorn; A Sill; W A Blattner; F Cocchi; D J Carlo; A L DeVico; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  STRL22 is a receptor for the CC chemokine MIP-3alpha.

Authors:  F Liao; R Alderson; J Su; S J Ullrich; B L Kreider; J M Farber
Journal:  Biochem Biophys Res Commun       Date:  1997-07-09       Impact factor: 3.575

3.  C-C chemokines, pivotal in protection against HIV type 1 infection.

Authors:  D Zagury; A Lachgar; V Chams; L S Fall; J Bernard; J F Zagury; B Bizzini; A Gringeri; E Santagostino; J Rappaport; M Feldman; S J O'Brien; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 4.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

Authors:  E A Berger; P M Murphy; J M Farber
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

5.  Inhibition of HIV-1 infection by the beta-chemokine MDC.

Authors:  R Pal; A Garzino-Demo; P D Markham; J Burns; M Brown; R C Gallo; A L DeVico
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

6.  Synthesis of proteins by native chemical ligation.

Authors:  P E Dawson; T W Muir; I Clark-Lewis; S B Kent
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

7.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; S K Arya; R C Gallo; P Lusso
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

Review 8.  Toward an understanding of the correlates of protective immunity to HIV infection.

Authors:  B F Haynes; G Pantaleo; A S Fauci
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

9.  Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor.

Authors:  S Struyf; P Proost; S Sozzani; A Mantovani; A Wuyts; E De Clercq; D Schols; J Van Damme
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

Review 10.  The B7 and CD28 receptor families.

Authors:  C H June; J A Bluestone; L M Nadler; C B Thompson
Journal:  Immunol Today       Date:  1994-07
View more
  23 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

2.  Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.

Authors:  M Scott Killian; Fernando Teque; Ramu Sudhagoni
Journal:  Immunogenetics       Date:  2017-07-22       Impact factor: 2.846

3.  Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status.

Authors:  Jennillee Wallace; Srinivas D Narasipura; Beverly E Sha; Audrey L French; Lena Al-Harthi
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

4.  Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.

Authors:  Avelino Teixeira; Benjamin Yen; Gabriele Luca Gusella; Albert G Thomas; Michael P Mullen; Judith Aberg; Xintong Chen; Yujin Hoshida; Harm van Bakel; Eric Schadt; Christopher F Basler; Adolfo García-Sastre; Arevik Mosoian
Journal:  J Infect Dis       Date:  2014-11-17       Impact factor: 5.226

5.  SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.

Authors:  Diana Ayinde; Timothée Bruel; Sylvain Cardinaud; Françoise Porrot; Julia G Prado; Arnaud Moris; Olivier Schwartz
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

Review 6.  Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology.

Authors:  Heng-Huan Lee; Ying-Nai Wang; Mien-Chie Hung
Journal:  Mol Aspects Med       Date:  2019-03-25

7.  CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons.

Authors:  M Scott Killian; Fernando Teque; Robert L Walker; Paul S Meltzer; J Keith Killian
Journal:  J Interferon Cytokine Res       Date:  2013-02-12       Impact factor: 2.607

8.  Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.

Authors:  Aaron Christensen-Quick; Mark Lafferty; Lingling Sun; Luigi Marchionni; Anthony DeVico; Alfredo Garzino-Demo
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 9.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

10.  Comparative analysis of bat genomes provides insight into the evolution of flight and immunity.

Authors:  Guojie Zhang; Christopher Cowled; Zhengli Shi; Zhiyong Huang; Kimberly A Bishop-Lilly; Xiaodong Fang; James W Wynne; Zhiqiang Xiong; Michelle L Baker; Wei Zhao; Mary Tachedjian; Yabing Zhu; Peng Zhou; Xuanting Jiang; Justin Ng; Lan Yang; Lijun Wu; Jin Xiao; Yue Feng; Yuanxin Chen; Xiaoqing Sun; Yong Zhang; Glenn A Marsh; Gary Crameri; Christopher C Broder; Kenneth G Frey; Lin-Fa Wang; Jun Wang
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.